April 11 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON AIMS TO SECURE FDA APPROVAL FOR IMM-124E TO PREVENT TRAVELERS' DIARRHEA
* IMMURON LTD - COMPANY ANTICIPATES SIGNIFICANT INFLECTION IN SALES WITH SUCCESSFUL FDA REGISTRATION OF IMM-124E
* IMMURON LTD - COMPANY TO PURSUE RAPID PATH FOR CLINICAL DEVELOPMENT OF IMM-124E
* IMMURON AIMS TO SECURE FDA APPROVAL FOR IMM-124E TO PREVENT TRAVELERS' DIARRHEA
* IMMURON LTD - FORECASTS IMM-124E'S POTENTIAL PEAK ANNUAL SALES AT OVER USD $100 MILLION ANNUALLY AS AN FDA APPROVED DRUG TO PREVENT TD